"","V1","V2","V3","V4","V5","V6","V7","V8","V9","V10","V11","V12","V13","V14","V15","V16","V17","V18","V19","V20","V21","V22","V23","V24","V25","V26","V27","V28","V29","V30","V31","V32","V33","V34","V35","V36","V37","V38","V39","V40","V41","V42","V43","V44","V45","V46","V47","V48","V49","V50","V51","V52","V53","V54","V55","V56","V57","V58","V59","V60","V61","V62","V63","V64","V65","V66","V67","V68","V69","V70","V71","V72","V73","V74","V75","V76","V77","V78","V79","V80","V81","V82","V83","V84","V85","V86","V87","V88","V89","V90","V91","V92","V93","V94","V95","V96","V97","V98","V99","V100","V101","V102","V103","V104","V105","V106","V107","V108","V109","V110","V111","V112","V113","V114","V115","V116","V117","V118","V119","V120","V121","V122","V123","V124","V125","V126","V127","V128","V129","V130","V131","V132","V133","V134","V135","V136","V137","V138","V139","V140","V141","V142","V143","V144","V145","V146","V147","V148","V149","V150","V151","V152","V153","V154","V155","V156","V157","V158","V159","V160","V161","V162","V163","V164","V165","V166","V167","V168","V169","V170","V171","V172","V173","V174","V175","V176","V177","V178","V179","V180","V181","V182","V183","V184","V185","V186","V187","V188","V189","V190","V191","V192"
"1","abs273.txt","background","","regorafenib","a","multikinase","inhibitor","that","inhibits","angiogenesis","growth","and","proliferation","prolongs","survival","as","monotherapy","in","patients","withrefractory","colorectal","cancer","this","international","double-blind","placebo-controlled","multicenter","trial","assessed","the","efficacy","of","withfolinic","acid","fluorouracil","irinotecan","(folfiri)","second-line","treatmentfor","metastatic","methods","with","who","progressed","on","first-lineoxaliplatin","fluoropyrimidine","enrolled","at","45","sites","united","states","andireland","stratified","by","prior","bevacizumab","use","were","randomized","2","1","toregorafenib","or","placebo","treatment","consisted","folfiri","days","anddays","15","16","160","mg","4","to","10","18to","24","every","28-day","cycle","crossover","was","not","allowed","primary","endpoint","wasprogression-free","(pfs)","under","assumption","75%","event","rate","180patients","required","for","135","events","achieve","90%","power","detect","hazardratio","(hr)","0","65","1-sided","α","value","results","one","hundred","eighty-one","(120","toregorafenib-folfiri","61","placebo-folfiri)","median","age","62","years","among","these","117","(65%)","received","aflibercept","pfs","longerwith","regorafenib-folfiri","than","placebo-folfiri","(median","6","vs","5","3","months","hr","73","95%","confidence","interval","[ci]","53-1","01","log-rank","p","=","056)","medianoverall","longer","(hr","ci","71-1","44)","response","ratewas","higher","(34%","25%-44%)","placebo-folfiri(21%","11%-33%","07)","grade","3/4","adverse",">5%","absoluteincrease","from","included","diarrhea","neutropenia","febrile","hypophosphatemia","hypertension","conclusions","addition","therapy","formetastatic","only","modestly","prolonged","over","alone","2018","©","american","society"
